Patents by Inventor Wieslaw Adam Mazur

Wieslaw Adam Mazur has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Melanocortin receptor ligands
    Patent number: 6911447
    Abstract: Disclosed are MC-3/MC-4 receptor ligands, the ligands having the following formula: wherein A is a conformationally restricted ring system selected from the group consisting of: a) non-aromatic carbocyclic rings; b) aromatic carbocyclic rings; c) non-aromatic heterocyclic rings; d) aromatic heterocyclic rings; wherein said rings comprises from 5 to 8 atoms; and W is a unit which preferable comprises D-1-fluorophenyalanine, Y comprises a heteroatom, and Z comprises an aromatic carbocyclic ring. Also disclosed are pharmaceutical compositions comprising the ligands of the invention as well as methods of treating diseases mediated through MC-3/MC-4 receptors.
    Type: Grant
    Filed: April 12, 2002
    Date of Patent: June 28, 2005
    Assignee: The Procter & Gamble Company
    Inventors: Wieslaw Adam Mazur, Xinrong Tian, Xiufeng Eric Hu, Frank Hallock Ebetino
  • Melanocortin receptor ligands
    Publication number: 20040224985
    Abstract: Disclosed are MC-3/MC-4 receptor ligands, the ligands having the following formula: 1
    Type: Application
    Filed: May 28, 2004
    Publication date: November 11, 2004
    Applicant: The Procter & Gamble Company
    Inventors: Wieslaw Adam Mazur, Xinrong Tian, Xiufeng Eric Hu, Frank Hallock Ebetino
  • Corticotropin releasing factor 2 receptor agonists
    Publication number: 20030148958
    Abstract: Isolated corticotropin releasing factor derivatives, and nucleic acids encoding the same, are effective for treating corticotropin releasing factor 2 receptor modulated disorders such as muscular dystrophy.
    Type: Application
    Filed: December 11, 2002
    Publication date: August 7, 2003
    Applicant: The Procter & Gamble Company
    Inventors: Robert Joseph Isfort, Wieslaw Adam Mazur
  • Corticotropin releasing factor 2 receptor agonists
    Publication number: 20030148956
    Abstract: Isolated corticotropin releasing factor derivatives, and nucleic acids encoding the same, are effective for treating corticotropin releasing factor 2 receptor modulated disorders such as muscular dystrophy.
    Type: Application
    Filed: December 11, 2002
    Publication date: August 7, 2003
    Applicant: The Procter & Gamble Company
    Inventors: Robert Joseph Isfort, Wieslaw Adam Mazur
  • Corticotropin releasing factor 2 receptor agonists
    Publication number: 20030148957
    Abstract: Isolated corticotropin releasing factor derivatives, and nucleic acids encoding the same, are effective for treating corticotropin releasing factor 2 receptor modulated disorders such as muscular dystrophy.
    Type: Application
    Filed: December 11, 2002
    Publication date: August 7, 2003
    Applicant: The Procter & Gamble Company
    Inventors: Robert Joseph Isfort, Wieslaw Adam Mazur
  • Melanocortin receptor ligands
    Publication number: 20030109556
    Abstract: Disclosed are MC-3/MC-4 receptor ligands, the ligands having the following formula: 1
    Type: Application
    Filed: April 12, 2002
    Publication date: June 12, 2003
    Applicant: The Procter & Gamble Company
    Inventors: Wieslaw Adam Mazur, Xinrong Tian, Xiufeng Eric Hu, Frank Hallock Ebetino